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Abstract
Background. The origin of Ewing’s sarcoma in a periosteal location is rare and not clearly documented. Other malignant
bone tumors appear to have a somewhat better prognosis when con® ned between periosteum and bone. Is it the same for
periosteal Ewing’s sarcoma?
Methods. We describe two new cases and comprehensively review the literature consisting of 18 documented cases since the
condition was ® rst described in 1986 (S.M. Bator. Cancer 58:1781± 4).
Results. Periosteal Ewing’s sarcoma differs from the other forms of Ewing’s sarcoma in terms of sex predominance, loca-
tion of tumor, surgical stage at presentation and typical imaging studies. Eighteen out of the 20 patients were reported to be
alive with no evidence of disease.
Conclusions. It seems that the prognosis of this rare variant of Ewing’s sarcoma family of tumors might be better but the
small number of cases precludes such a ® rm conclusion.
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Introduction
The classi® cation of primary malignant bone tumors
is still expanding to include new subtypes based upon
the clinical presentation, radiographic features
(including modern imaging modalities such as
computed tomography (CT), magnetic resonance
imaging (MRI), positron emission tomography scan
(PET scan) and others,
1± 4 anatomical localization
and new sophisticated modern cytogenetic and
molecular biology techniques.
5± 9
It is obvious that the classical histological/
morphological methods of classifying bone tumors
are crude and not of sufficient accuracy to distinguish
subtypes. Subtyping is most probably of prognostic
signi® cance, but might have therapeutic implications.
Many think that bone tumors arising in a periosteal
location (surface lesions) have a somewhat better
prognosis than those arising in the medullary cavity
of the same bones.
10± 11 Ewing’s sarcoma (ES) is one
of the best examples of a distinctive tumoral disease
which, based upon clinical radiological and cytoge-
netic parameters,
1,9 which, is considered today to be
a group of different diseases. According to the
anatomical site today we recognize three subtypes:
(a) the intraosseous type, which is the most
common;
12 (b) the extraskeletal or soft tissue type
(less common);
13± 14 and (c) the very rare variant of
periosteal location of which only 18 cases are
described in the literature so far.
15± 19. The ® rst
description of periosteal Ewing’s sarcoma (PES) was
probably that published in 1956 by Sherman and
Soong in a comprehensive radiological review of 111
cases of ES of bone which included a roentgen clas-
si® cation.
20They described three cases of PES among
12 other cases, which they de® ned as ª cortical Ewing’s
sarcoma of long bones,º but without mentioning the
name and obviously based only upon plain X-ray
® lms and classical histological criteria.The ® rst well-
established case report of PES was published in 1986
by Bator et al.
15 He actually de® ned PES: ª . . . in a
periosteal location without extension into either the
bone or adjacent soft tissuesº . Since then four
additional papers, describing a total of 18 cases, have
been published.
16± 19We add to this list two new cases
and review the literature.
Case reports
(1) A 16-year-old male patient was referred to the
Orthopedic Oncology Unit in our center on July 1994.
He complained of a growing, large (>10 cm) painful
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his right thigh, which he had experienced for 3
months. His general condition was good except for
low fever for the last few months. Physical examina-
tion revealed a tender longitudinal mass along the
biceps muscle in the right distal thigh, 12.5 cm in
size. No palpable lymph nodes were noted in the
groin or other places. Blood tests showed an elevated
erythrocyte sedimentation rate (ESR) of 100/120;
normal white blood cell (WBC) count; normal
alkaline phosphatase (AP) blood levels; and a slight
increase of lactate dehydrogenase (LDH) blood levels.
Plain X-ray ® lms of the thigh and knee region showed
priosteal elevation and thickening. Our differential
diagnosis was of an infectious disease, such as primary
osteomyelitis, or secondary to a soft tissue process or
some form of a malignant surface bone neoplasm.
Protocol staging studies included: plain chest X-ray
® lm; total body bone scan; CT of the lesion and
chest; and MRI of the lesion. The CT and MRI of
the distal femur showed a periosteal/surface lesion, as
the medullary canal and the endosteal surface of the
distal femur were intact.The systemic bone scan and
chest CT were normal. The patient underwent an
open incisional biopsy under general anesthesia.The
histopathological results indicated a classical ES in a
periosteal location. According to AMSTS (Ennek-
ing’s) surgical staging system the patient was in stage
II-B.
21 He received neoadjuvant chemotherapy and,
in December 1994, underwent a limb-sparing opera-
tion where the distal half of the right femur and knee
joint were resected including the lateral hamstring
muscles and biopsy scar. The defect was replaced by
a modular endoprosthesis. Histopathological evalua-
tion of the specimen showed 100% necrosis and
practically no tumor mass was found. He continued
the same chemotherapy until July 1995.The area was
not irradiated and during the follow-up period of 3
years since then he has been free of disease.
(2) A 27-year-old male patient was referred to our
unit on October 1995 because of a painful growing
mass in the medial aspect of his right thigh for 2½
months. His general condition was good. Physical
examination showed a tender longitudinal lesion in
the right mid-medial aspect of his thigh. There was
no evidence of palpable lymph nodes in any loca-
tions. Blood tests, including ESR, WBC count, AP
and LDH, were all normal. Conventional radiograph
of the femur showed generalized periosteal thickening,
with an area of bulging periosteum and a slight
hypodense region within it. A soft tissue component
was noted (Fig. 1). Our differential diagnosis was
either a soft tissue tumor encroaching upon the bone
or a malignant surface bone neoplasm. Staging studies
included plain chest X-ray ® lm; total body bone scan;
CT of the lesion and chest and MRI of the lesion. As
in the previous case, the CT and MRI of the thigh
showed a periosteal/surface lesion without any involve-
ment of the medullary canal (Fig. 2). Systemic bone
scan and chest CT were normal. On October 1995
he underwent a core needle biopsy. The histopatho-
logical result was classical ES in a periosteal location.
According to AMSTS the patient was in stage II-B.
21
Neoadjuvant chemotherapy and preoperative
radiotherapy (4500 rad) were given. He underwent a
limb-sparing procedure where one-half of the
mid-femoral shaft and adductor muscles were
resected.The defect was reconstructed with an intra-
medullary nail and autologous bone graft. Histopatho-
logical evaluation of the specimen showed 100%
necrosis. He continued chemotherapy and post-
operative radiotherapy up till February 1997 and
during the follow-up period of 1.5 years the patient
has remained free of disease.
Review of the literature (18 cases)
Eighteen cases, described in ® ve papers published
from 1986 to 1994,
15± 19 together with the two new
cases, comprise this survey.
There were 17 males and three females aged
between 11 and 30 years. Presenting symptoms were
mentioned for 14 of the 20 patients
15,17± 19 and
included: pain (four patients), a mass (one patient)
and a combination of both in the remaining nine
patients. Duration of symptoms varied between 10
days and 4 months (mean, 2 months). In 16 cases the
tumors were located in the proximal long bones (six
in the humerus and 10 in the femur), two in the tibia,
Fig. 1. Conventional radiograph of the femur shows generalized
periosteal thickening with an area of bulging periosteum and a
slight hypodense region within it. A soft tissue component is
noted.
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cases the tumor was diaphyseal and in three it was
metadiapheaseal. All patients were at stage II-B at
presentation (according to AMSTS),
21 meaning that
no metastases were detected in baseline staging studies.
Non-surgical treatment included chemotherapy for
all 20 patients.For 14 patients details were noted about
the method by which chemotherapy was given.In 13 of
the 14 cases neoadjuvant chemotherapy was given and
in one case adjuvant chemotherapy was given. Precise
documentation about the timing of radiation therapy
was also noted for 14 of the 20 patients. Of these, ® ve
patients received external beam radiation therapy (two
patients received only preoperative radiation therapy
and three patients received combined pre- and post-
operative radiation therapy). All of the remaining six
patients received radiation therapy, but whether it was
pre- or post-operative was not stated. Hence, 11 of the
20 patients received radiotherapy.
Nineteen of the 20 patients had tumors located in
long bones (one was at the scapula). Of these 19
patients, 18 underwent limb-sparing surgery and one
underwent amputation.
Follow-up periods stated in the papers at publica-
tion were between 2 months and 10 years, with a
mean of 3 years. For 11 patients follow-up periods of
more than 2 years were noted. Two patients were
dead, at 1 and 2 years after end of therapy, and the
remaining 18 patients were alive with no evidence of
disease.The fate of the patients after the publication
of the papers is not known to us.
Discussion
Concerning the clinical presentation and age distribu-
tion, no differences between PES and other forms of
ES
1,12,22 have been shown. There are differences,
however, between PES and the other forms of ES
with regard to sex predominance, location of tumor
and surgical stage at presentation. A clear male
predominance is noted in PES (the male to female
ratio is 5.7:1),
15± 19 while in medullary ES only a
slight male predominance, with a male to female ratio
of about 1.5:1, is known
23,24 and there has been no
male predominance in extraskeletal ES reported.
13,14.
Medullary
12,23± 24 and extraosseous
13,14,25 ES
develop in both proximal and distal long bones and
axial ¯ at bones. PES shows a predominance in
proximal extremities and axial PES is uncommon.
Only one case of PES in an axial ¯ at bone (scapula)
was reported by Kolar et al.
16 The small number of
cases precludes a real statistical signi® cance to these
clinical observations which show only trends.
In PES, all 20 patients were diagnosed at stage
II-B of the disease, with no evidence of distant metas-
tases. In comparison, metastases at presentation occur
in about 25% of cases of medullary ES
12,23 and in
about 10% of cases of extraskeletal ES.
13
Imaging studies help to con® rm the diagnosis of
PES which is de® ned when there is no tumor invasion
of the medullary cavity.
10,11,26± 29.A subperiosteal mass
with a periosteal thickening and a Codman triangle are
diagnostic.
10,11,26± 30 These radiological signs appear
both in PES and medullary ES, but PES usually shows
a uninterrupted periosteal reaction compared with the
`onion skin’ periosteal reaction observed medullary
ES.
20 A subperiosteal location and the absence of
medullary bone involvement help to distinguish PES
from the other types of ES.
3,4,15± 17,20,31,32
Although conventional radiography provides the
most useful information for diagnosis and for gauging
biological aggressiveness of the tumor, it has some
limitations in estimating the extent of intramedullary
disease in medullary ES or in soft tissue involve-
ment.
1Tumor size and the accurate margins between
the intramedullary space, the periosteal location and
the soft tissue can be adequately determined only by
imaging studies such as CT or MRI.
1 The typical
picture of PES is of a periosteal tumor which has not
invaded the medullary cavity.
15± 19 Extraskeletal (soft
Fig. 2. CT scan of the mid-femur shows a periosteal mass with a soft tissue component. A scalloping of the cortext is seen.The density
of the medulla appears normal.
Periosteal Ewing’s sarcoma 87tissue) ES tumors which grew enough to invade the
periosteum will be de® ned as PES, so there might be
an overlap between the two subtypes. Still, the entity
of PES is quite well established, and there is a differ-
ence between the periosteal form and the soft tissue
form in terms of sex, anatomical location in bones
and staging at diagnosis.
At histopathological examination, all subtypes of
ES, whether medullary, extraskeletal or periosteal,
appear the same. In general, ES consists of uniform,
small, round or oval highly undifferentiated cells with
a pale appearance and scanty cytoplasm. It contains
glycogen-positive granules with positive periodic acid±
Schiff stain.
12± 17,25
It is not understood why PES seems to have a
better prognosis than the other two forms. This
observation is similar to that of a better prognosis in
periosteal osteosarcoma and periosteal chondrosar-
coma than in their medullary counterparts.
10,11 One
possible explanation is that the location at the perios-
teum causes such pain that the patients seek medical
help earlier. Another possible explanation can be
found in the cytogenetic pro® le of the patients. None
of the 18 patients in the ® ve articles reviewed, together
with our own two patients, underwent cytogenetic
analysis. The reason for this favorable prognosis may
be the latter. It is strongly recommended that such an
analysis is performed for PES patients in the future.
After reviewing the literature it seems to us that
this rare entity should be considered in the differential
diagnosis of the ES family of tumors since there is a
possibility that it has a better prognosis than medul-
lary or soft tissue ES.
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